The present invention relates to hydrazone compounds of Formula I: (I) and pharmaceutically acceptable salts and stereoisomers thereof, wherein R1, R2, R3, R4, L1, and L2 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I as inhibitors of TRPM5 protein.
本发明涉及式I的腙化合物:(I)及其药用可接受的盐和立体异构体,其中R1、R2、R3、R4、L1和
L2的定义如规范中所述。该发明还涉及将式I的化合物用作TRPM5蛋白的
抑制剂。